Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Relmada Therapeutics Inc
(NQ:
RLMD
)
2.500
-0.070 (-2.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
77,565
Open
2.630
Bid (Size)
2.350 (1)
Ask (Size)
2.710 (1)
Prev. Close
2.570
Today's Range
2.350 - 2.760
52wk Range
1.880 - 7.223
Shares Outstanding
17,472,986
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q2 2024
August 07, 2024
RLMD stock results show that Relmada Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
June 05, 2024
Via
Benzinga
Performance
YTD
-42.79%
-42.79%
1 Month
-32.80%
-32.80%
3 Month
-25.15%
-25.15%
6 Month
-55.28%
-55.28%
1 Year
-12.28%
-12.28%
More News
Read More
7 Penny Biotech Stocks to Triple Your Investment
May 28, 2024
Via
InvestorPlace
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q1 2024
May 08, 2024
Via
InvestorPlace
RLMD Stock Earnings: Relmada Therapeutics Misses EPS for Q4 2023
March 19, 2024
Via
InvestorPlace
Recap: Relmada Therapeutics Q4 Earnings
March 19, 2024
Via
Benzinga
Earnings Outlook For Relmada Therapeutics
March 18, 2024
Via
Benzinga
Earnings Outlook For Relmada Therapeutics
November 07, 2023
Via
Benzinga
Earnings Scheduled For March 19, 2024
March 19, 2024
Via
Benzinga
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying
February 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 04, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 21, 2023
Via
Benzinga
Relmada Therapeutics' Lead Candidate Shows Promise In Pivotal Depression Study
September 20, 2023
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm
August 11, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
August 07, 2023
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm
August 06, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick
July 31, 2023
Via
InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Relmada, Arrival, FMC, and Viasat and Encourages Investors to Contact the Firm
July 26, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Relmada, DoubleVerify, and Castle and Encourages Investors to Contact the Firm
July 21, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm
July 16, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Chegg, and Relmada and Encourages Investors to Contact the Firm
July 10, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Shift4, Waldencast, Chegg, and Relmada and Encourages Investors to Contact the Firm
July 05, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Seagate, Chegg, Relmada, and DoubleVerify and Encourages Investors to Contact the Firm
July 01, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.